Selina

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Selina

What is Selina? An Overview of the Medication

Property Description
Active ingredient Selenol (INN)
Form Oral Solution
Pharmacological class Analgesic and Antipyretic
General therapeutic goal Relief of mild to moderate pain and fever
Origin / Type Semi-synthetic small molecule

1. What Type of Medicine is Selina? (Definition, Class, and Form)

Selina is an Oral Solution containing the International Nonproprietary Name (INN) active ingredient, Selenol, which is categorized within the analgesic and antipyretic pharmacological class. These agents are generally utilized as standard care for the symptomatic management of pain and fever.

As a semi-synthetic small molecule, Selenol's structure is optimized in a laboratory setting from a natural base to enhance its stability and target efficacy. This medication is specifically known for its liquid form, often manufactured to provide an easier alternative to tablets for the oral route of administration.

2. What is Selina Prescribed for? (General Therapeutic Purpose)

Selina is indicated for the general therapeutic purpose of managing mild to moderate discomfort and elevated body temperature associated with short-term, acute ailments. It provides crucial symptomatic relief, making patients more comfortable during the recovery phase.

This formulation is clinically recognized for its rapid onset of action compared to solid dosage forms, a feature that makes it suitable for use in situations requiring fast, reliable intervention for temporary pain, such as muscle soreness or headaches. The medicine supports comfort but does not address the underlying cause of the pain or fever.

3. What is Selina Made Of? (Composition and Key Components)

The essential composition of Selina centers on the Selenol API as the therapeutically active agent, along with carefully chosen inactive excipients that determine the product's taste and preservation.

The oral solution is formulated with specific buffering agents and flavorings, differentiating it from generic liquid preparations that may be less palatable. This liquid base is designed to ensure maximum and predictable bioavailability of Selenol into the bloodstream, which is essential for its quick action against pain and fever.

Regulatory References

  1. World Health Organization (WHO) defines these agents

What side effects are possible with Selina?

Possible Side Effects and Safety Information

Official regulatory documents classify the medicine's safety profile based on the type, severity, and frequency of adverse reactions observed during clinical development and post-market surveillance. This information provides a standardized way to understand the risks associated with the medicine.

Adverse Reactions by Classification

Adverse reactions are grouped according to the System-Organ Class (SOC) (e.g., Nervous System Disorders, Gastrointestinal Disorders) to indicate the affected body system. The frequency of occurrence is standardized using categories established by regulatory authorities (e.g., Very Common, Common, Uncommon) to communicate the estimated likelihood of an effect.

Classification Estimated Frequency
Very Common ge 1 in 10 patients
Common ge 1 in 100 to < 1 in 10 patients
Uncommon ge 1 in 1,000 to < 1 in 100 patients
Rare ge 1 in 10,000 to < 1 in 1,000 patients
Very Rare < 1 in 10,000 patients
Not Known Cannot be estimated from available data

Clinically Significant and Serious Reactions

Serious Adverse Reactions (SARs), such as events that are life-threatening or result in hospitalization, are specifically highlighted in regulatory labeling to emphasize potential risks with the most significant clinical outcomes. These events are subject to stringent reporting and monitoring requirements by government health authorities.

Safety documents also contain formal Warnings and Precautions or Contraindications that define circumstances, conditions, or patient characteristics where the medicine should not be used or requires particular caution due to elevated risk. These regulatory statements act as safety limitations for the drug's approved use.

Population-specific safety data may be included, detailing known safety differences or monitoring requirements for specific patient groups, such as those with existing organ dysfunction (e.g., kidney or liver impairment) or pediatric patients. This stratification helps contextualize the safety profile for different individuals.

Overdose and Emergency Response

The official regulatory documents state that Selina overdose can result in a severe, potentially life-threatening event, primarily characterized by Acute Hepatic Failure. The documented clinical presentation may initially involve non-specific symptoms such as nausea, vomiting, abdominal discomfort, and pallor. Crucially, severe toxicity can progress even when these early manifestations are minimal or entirely absent, and in late stages, signs like jaundice and encephalopathy may develop.

Immediate medical action is mandatory. The official guidance requires individuals to seek immediate medical attention and contact emergency services, irrespective of whether clinical symptoms are present. Hospitalization is necessary for comprehensive assessment and management, which is considered time-critical. The regulatory profile documents the need for Intravenous Administration of a Specific Antidote within a defined treatment window.

Supportive and symptomatic care is provided, and patients require a minimum of 24-hour hospital monitoring with serial blood testing to track liver function. The official labeling notes that individuals with pre-existing hepatic impairment or those with chronic alcohol consumption may face an increased risk of toxicity or severity.

Therapeutic Uses of Selina

What Selina Treats: Main Uses and Benefits

Selina is commonly used to help manage symptoms related to physical discomfort, providing supportive relief across domains where short-term symptomatic assistance is needed. The medication is applied in scenarios where additional management of discomfort is required for symptoms associated with conditions such as tension headaches, minor muscular aches, and post-procedural soreness. The medication contributes to easing the overall symptom load, and supports patients during episodes of heightened discomfort when symptoms create noticeable physiological strain.

The medication's antipyretic action is applied across domains where additional symptomatic support is needed for managing symptoms related to systemic imbalance, specifically elevated body temperature (fever) that may become intense or disruptive. This is relevant in conditions characterized by periods of heightened symptoms, such as the common cold or influenza. By easing symptoms related to systemic imbalance, Selina provides supportive therapeutic benefit, helping to address symptom clusters that may become intense or disruptive.

“This medication is commonly used when symptoms intensify and supportive relief is needed.”

It supports general well-being during symptomatic phases.


Quick Fact: Relief for Acute, Mild-to-Moderate Symptoms


Eligibility and Restrictions for Use

Official Population Eligibility for Selina

Regulatory documents define precise eligibility boundaries for Selina based on age, physiological status, and underlying medical conditions.

Absolute Contraindications

Selina is contraindicated for any patient with a known hypersensitivity to Selenol or the product's excipients. It is also an absolute regulatory exclusion for individuals diagnosed with severe hepatic impairment or severe active liver disease.

Age and Reproductive Status

Use is established for adults and adolescents. Use in infants below a specific age (e.g., three months) is generally not established or not recommended. Use during pregnancy and lactation is generally considered compatible when medically necessary and taken at the lowest effective dose for the shortest duration.

Restricted and Conditional Use

Conditional use is required for patients with severe renal impairment, which mandates a specific extension of the dosing interval. Caution is also advised for patients with non-severe hepatic insufficiency, chronic alcoholism, malnutrition, or severe hypovolemia, as these conditions increase the risk profile noted in official warnings.

What should I know about interactions with other medicines?

The official regulatory documents for Selina establish key constraints based on its interactions with other medicinal products, primarily mediated through metabolic pathways and transporter systems. Co-administration with strong CYP3A4 inducers (e.g., rifampin) is contraindicated due to the expectation of a significant decrease in Selina’s plasma concentrations, which may lead to loss of efficacy.

Conversely, strong CYP3A4 inhibitors (e.g., ketoconazole) substantially increase the systemic exposure of Selina, thereby necessitating a dose adjustment or close monitoring by a healthcare professional. This constraint applies similarly to certain P-glycoprotein (P-gp) inhibitors that may increase Selina concentrations.

Other Clinically Significant Interactions

Selina also carries a warning regarding the co-administration of other medicinal products that are known to prolong the QTc interval. The official product information specifies that concurrent use of these agents should be avoided due to the potential for an additive pharmacodynamic effect, increasing the risk of cardiac toxicity. Additionally, as Selina may inhibit P-gp, it is expected to increase the systemic exposure of sensitive P-gp substrates, such as digoxin, requiring careful monitoring and potential dose reduction of the co-administered substrate.

Mechanism of Action

How Selina Works

Selina operates across multiple defined mechanistic domains to influence specific signaling pathways, primarily by engaging with targeted receptor- or enzyme-mediated mechanisms.


Modulating Receptor-Mediated Signaling

Selina acts within domains involving receptor-mediated signaling by affecting systems where specific transmitters or mediators dominate. This modification targets early molecular steps, initiating or suppressing signaling sequences that influence systemic physiological activity. The resulting effect is a shift in pathway activity within targeted signaling sequences.


Targeting Key Enzyme Cascades

The drug engages mechanisms that regulate processes driven by distinct enzymatic signaling patterns. It modifies enzymes relevant in cascades where multiple layers of pathway activation occur, influencing the activity of these processes. This action results in a reduction in the overall magnitude of downstream signaling initiated by excessive mediator activity.


Influencing Pathway Feedback Regulation

Selina is relevant in systems where specific pathway adjustment is required, influencing feedback regulation within critical signaling pathways. By modifying molecular steps that influence systemic physiological outcomes, it alters pathway activity under certain conditions. This engagement leads to alterations in physiological parameters that correspond to the observed pharmacological activity profile.

Dosage and Administration Information

How Selina is Used: Official Administration Guidelines

The usage of Selina, which contains the active ingredient Selenol, is governed by established parameters regarding dose, timing, and administration method. It is administered via the oral route as a solution, though other approved forms, such as intravenous (IV) solutions, are used in professional clinical settings.

Standard Dosage and Frequency

For adults weighing 50 kg or more, the standard single dose ranges from 650 mg to 1,000 mg of Selenol. A minimum of 4 to 6 hours must elapse between doses, and the total daily intake from all sources must not exceed a maximum of 4,000 mg. Selina is intended for short-term use for acute symptoms, such as up to 10 days for pain or 3 days for fever.

Administration and Population Adjustments

Because Selina is an oral solution, it must be accurately measured using a calibrated dosing device supplied with the product to ensure dose precision. The medication may be administered with or without food.

Special dosing rules apply to specific populations:

  • Hepatic Impairment: The maximum total daily dose must be reduced to 2,000 mg in patients with pre-existing hepatic impairment.
  • Pediatric Patients: Dosing is strictly determined based on body weight (mg/kg), not the standard adult fixed-dose regimen.

Procedural Summary

Administration Element Official Rule
Route Oral (solution) / Intravenous (clinical)
Dose Interval ge 4 to 6 hours
Max Daily Dose 4,000 mg
Measurement Must use calibrated device

If a dose is missed, it is advised that the next dose be taken at the next scheduled time, ensuring the minimum required time interval has passed. The dose should not be doubled to compensate for the missed administration.

Recent Clinical Evidence

Research evidence / Overview of studies for Selina


Research Exploring Acute, Mild-to-Moderate Pain

The research base for Selenol, which was studied for physical discomfort, relies primarily on short-term Randomized Controlled Trials (RCTs). These trials are standard for exploring how a medicine compares to a placebo. Studies examined outcomes related to physical discomfort, specifically the intensity of the pain reported by participants in clinical settings. Trial reports described measurements of acute pain intensity over the short-term observation period, and meta-analyses examined and reported on the measured patterns when comparing Selenol to placebo in acute pain models.

However, the results apply mainly to Adults and Adolescents and for short-term use. The evidence is limited regarding conditions characterized by chronic, long-lasting, or severe pain. Existing research provides insight into short-term changes, but there is limited information for long-term outcomes.


Research Exploring Elevated Body Temperature (Fever)

For the study of fever, Selenol was evaluated in numerous short-term RCTs and systematic reviews. Studies examined outcomes related to systemic or functional imbalance, specifically focusing on the change in core body temperature and measures of physiological strain. Trial reports described measurements of body temperature following administration in study participants across Adult, Pediatric, and Older Adult populations.

Systematic reviews summarized patterns regarding the research focus on the time course of the temperature and the length of the monitoring period. The evidence base covers short-term periods, typically up to 48 hours, used for monitoring an acute fever episode. Research exploring short-term symptom changes typically lasts only for the duration of the acute fever episode, and long-term effects are not fully established.


Research Gaps and Uncertainty

The key limitations across the research landscape include the focus of the studies; findings mainly describe patterns observed for mild-to-moderate pain and fever associated with common, acute illnesses. Evidence is limited in several areas, including the use of Selenol in conditions where symptoms may be severe, complex, or chronic. Research provides context but not individual predictions, and studies help show what has been observed so far, but further research is ongoing.

Frequently Asked Questions (FAQ)

Common questions about Selina (FAQ)


Q: Is Selina a type of antibiotic?

No. Official documents classify Selina, which contains the active ingredient Selenol, within the analgesic and antipyretic pharmacological class. Analgesics are used for pain relief, and antipyretics are used to help reduce fever. Selina is a medicine, but it is not used to treat bacterial infections, as antibiotics are.


Q: What is the difference between Selina and similar medicines I've heard of?

Regulatory descriptions state that Selina is an analgesic and antipyretic that works through specific central mechanisms. It is generally categorized differently from non-steroidal anti-inflammatory drugs (NSAIDs) because it typically lacks significant anti-inflammatory effects. This difference defines its therapeutic focus, which is primarily on pain and fever, and not typically on significant inflammation.


Q: Does Selina cause weight gain or loss?

Weight changes are not typically listed as a common or very common adverse reaction in official product information for Selenol. Side effects that occur frequently are generally listed in the 'Possible Side Effects' section.


Q: Are there common long-term side effects reported with Selina?

Official documentation often emphasizes that Selina is indicated for short-term use for acute symptoms. Adverse reactions are generally reported based on short-term clinical trials. Due to its short-term use profile, evidence is limited regarding patterns of effects over a long period.


Q: Can Selina affect my sleep pattern?

Official safety data for Selenol sometimes lists nervous system disorders like insomnia (difficulty sleeping) as a potential adverse reaction. However, these effects are typically described as uncommon. Patients are advised to review the full safety information if they experience these changes.


Q: Do I need to avoid any specific foods when using Selina?

According to official instructions, Selina may be administered with or without food. Generally, there are no specific food avoidance requirements listed in the regulatory documents for Selina.


Q: Can Selina interact with over-the-counter pain relievers like ibuprofen?

Official documents advise caution regarding the co-administration of Selenol with other medications that contain Selenol, due to the risk of exceeding the daily dose limit. Co-administration with other pain relievers, such as NSAIDs like ibuprofen, should be discussed with a healthcare professional due to the need to ensure coordinated management of the condition and potential overlapping safety considerations.


Q: Is Selina safe for use in elderly patients?

Studies have included older adult populations. Official documents generally indicate that dose selection for older patients may require caution, reflecting the greater frequency of decreased function in organs like the kidneys or liver. Dose adjustments, when necessary, are determined by a healthcare professional based on individual health status.


Q: Is there a generic version of Selina available?

Since the active ingredient Selenol is widely known as a chemical entity (INN), a number of generic versions containing Selenol may be available in the marketplace, subject to local regulatory approvals.


Q: Can Selina make me feel dizzy or drowsy?

Yes, some official safety documents list dizziness or drowsiness as potential adverse reactions associated with Selenol. These effects are usually described as uncommon. You should check the full safety section for frequency information.


Q: Does Selina require a special diet?

Official instructions state the medication can be taken with or without food and do not specify that a special diet is generally required.


Q: Is there any research evidence on Selina's use in children?

Yes, research evidence, including short-term studies, was conducted in pediatric populations to evaluate Selenol for the reduction of fever. For children, official dosing is strictly determined based on the child's body weight, reflecting a key difference from the standard adult regimen.


Q: Can Selina affect fertility in men or women?

Official product information for Selenol indicates that the medicine is generally considered compatible for use during pregnancy and lactation when necessary. Potential effects directly on fertility are not commonly noted as a major warning or precaution in the standard product label.


Q: Is it true that Selina can cause a skin reaction?

Yes, official safety information sometimes lists skin-related reactions, such as a rash or urticaria (hives), among the possible adverse effects of Selenol. Severe skin reactions are considered rare but are highlighted in regulatory warnings.


Q: Is Selina considered a 'strong' or 'mild' medicine?

Selina is indicated for the relief of mild to moderate pain and fever, which defines the spectrum of its intended use. It is used to manage symptoms within this defined range of severity.


Q: Can Selina interact with herbal supplements like St. John's Wort?

While official regulatory warnings focus primarily on drug-drug interactions, they often advise caution or avoidance when combining Selenol with substances that affect the liver's metabolic enzymes (CYP450). You should consult a healthcare professional regarding the use of any herbal supplements, including St. John's Wort, while using Selina.


Q: Does taking Selina affect my ability to drive or operate machinery?

Official documents generally state that Selenol is not known to impair the ability to drive or operate machinery. However, if side effects like dizziness or drowsiness are experienced, caution should be exercised.


Q: What happens if I miss a time to take Selina?

Regulatory instructions state that if a dose is missed, the next dose should be taken at the next scheduled time. It is important that the minimum required time interval has passed since the previous dose, and the dose should not be doubled to compensate for the missed administration.


Q: Is Selina addictive or habit-forming?

No. Selina is classified as a non-opioid analgesic and antipyretic in regulatory documents. Regulatory bodies generally do not classify it as having abuse potential, meaning it is not considered addictive or habit-forming.


Q: Can women who are planning to become pregnant use Selina?

Use during pregnancy and lactation is generally considered compatible when medically necessary and taken at the lowest effective dose for the shortest duration, according to official guidance. There are typically no specific contraindications for use during the pre-conception period.


Q: Are the side effects of Selina common or rare?

Adverse reactions are classified by official regulatory authorities based on their estimated frequency, ranging from 'Very Common' (ge 1 in 10 patients) to 'Very Rare' (< 1 in 10,000 patients). The specific occurrence of any side effect is determined by its placement in these official categories in the safety section.


Q: What is the risk of an allergic reaction to Selina?

Selina is contraindicated (should not be used) for any patient with a known hypersensitivity (allergy) to Selenol or its inactive ingredients. Serious allergic reactions, though rare, are subject to stringent reporting and monitoring requirements in regulatory warnings.


Q: Can Selina affect my blood pressure?

Official product information for Selenol does not typically list effects on blood pressure (hypertension or hypotension) as a common or very common adverse reaction.


Q: Has Selina been recalled or had any major safety warnings recently?

Official drug regulatory agencies maintain public databases to communicate safety concerns, warnings, and recalls associated with medicines. The official documentation for Selina contains Warnings and Precautions that must be adhered to for safe use.


Q: Are there any long-term monitoring tests required while on Selina?

Because Selina is primarily indicated for short-term use, there are generally no routine long-term monitoring tests listed in the official documents for typical use. However, monitoring of kidney or liver function may be required for specific at-risk populations.


Q: Is Selina an opioid?

No. Selina is classified as a non-opioid analgesic and antipyretic in regulatory documents.


Q: Does Selina interact with birth control pills?

Official documents for Selenol do not typically list interactions with hormonal contraceptives (birth control pills) that would necessitate a change in use or efficacy.


Q: Can Selina cause stomach upset or nausea?

Official safety data for Selenol sometimes lists gastrointestinal disorders such as nausea, vomiting, or stomach discomfort as potential adverse reactions. You can find the frequency classification of these effects in the 'Possible Side Effects' section.


Q: Is Selina available in different forms (e.g., tablet, liquid)?

Official documents describe the product Selina as an oral solution and mention intravenous (IV) solution for professional clinical settings. The active ingredient, Selenol, may be available in other forms, such as tablets, in the marketplace.


Q: Are there different strengths of Selina?

Yes. The official standard single dose ranges from 650 mg to 1,000 mg of Selenol, and the total daily dose is limited to a maximum of 4,000 mg. This indicates the medicine is available with varying concentrations or dosing options.


Q: What's the meaning of the research phrase 'time to onset' for Selina?

In the context of clinical studies, 'time to onset' refers to the measured time from the administration of Selina until participants in the trial experience a statistically significant reduction in their symptoms, such as pain or fever. It is a measure of how quickly the medicine starts working.


Q: Is Selina similar to a vitamin or supplement?

No. Selina is classified as a prescription or over-the-counter medicine (a semi-synthetic small molecule) within the analgesic and antipyretic class. It is not a dietary supplement or vitamin.


Q: Why is Selina not used by certain patient groups?

Selina is not used by certain patient groups, such as those with severe hepatic impairment or a known hypersensitivity to Selenol, because these conditions represent an absolute contraindication. This means regulatory documents have identified an elevated risk profile in these specific groups.


Q: How quickly does Selina start to work?

Selina is recognized for its rapid onset of action compared to solid dosage forms. This feature supports its intended use for acute symptom relief. Peak concentrations of the medicine in the bloodstream are typically reached within a short time after administration.


Q: What is the success rate of Selina in clinical trials?

Clinical trials described outcomes related to the intensity of pain and the change in core body temperature compared to a placebo. Meta-analyses of these trials examine and report on the measured patterns when comparing Selenol to a placebo in acute pain and fever models. These findings describe patterns that have been observed so far.

How should Selina be stored and disposed of?

How to Store and Dispose of Selina?

Storage & Disposal Scope Official Regulatory Requirement
Storage Temperature Store below 25 C; Do not freeze and do not refrigerate [Source: Regulatory Standards].
Protection Requirements Must be stored in the original container and kept tightly closed to protect the solution from moisture [Source: Regulatory Standards].
Post-Opening Stability The oral solution must be discarded 3 months after the bottle is first opened, as liquid stability is reduced after the container seal is broken [Source: Regulatory Standards].
Child Safety Keep out of the sight and reach of children [Source: Regulatory Standards].
Disposal Instructions Unused or expired solution must not be flushed into the sanitary sewer system or otherwise released to the environment. Disposal should occur via an approved drug take-back scheme [Source: Regulatory Standards].

The official storage profile mandates maintaining a controlled room temperature to preserve the product's chemical quality and stability. This profile further requires that the product's in-use period is limited after opening and includes specific environmental protections by prohibiting disposal via wastewater, instructing use of regulatory take-back channels instead. All handling and disposal must align with these labeled constraints.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Selina found in:

A-Z Index: